课题基金 / 基金详情

A COMBINATION TRIAL OF COPAXONE PLUS ESTRIOL IN RELAPSING REMITTING MULTIPLE

A COMBINATION TRIAL OF COPAXONE PLUS ESTRIOL IN RELAPSING REMITTING MULTIPLE
科帕松加雌三醇治疗多发性复发缓解的联合试验
批准号：
7724538
负责人：
RHONDA R VOSKUHL
金额：
$0.52万
依托单位：
UNIVERSITY OF CALIFORNIA LOS ANGELES
依托单位国家：
美国
项目类别：
财政年份：
2008
资助国家：
美国
项目状态：
已结题
起止时间：
2008-08-01 至 2009-07-31
来源：
https://reporter.nih.gov/project-details/7724538
关键词：
Computer Retrieval of Information on Scientific Projects DatabaseCopaxoneDiseaseEstriolFundingGrantImageInstitutionMeasuresOralRateRelapseRelapsing-Remitting Multiple SclerosisResearchResearch PersonnelResourcesSourceUnited States National Institutes of HealthWomandouble-blind placebo controlled trial

项目摘要

项目成果

RHONDA R VOSKUHL的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. "A combination trial of copaxone plus estriol in relapsing remitting multiple sclerosis" A multicenter double blind placebo controlled trial to determine if oral estriol treatment is effective in decreasing disease activity in women with relapsing remitting multiple sclerosis as measured by relapse rate, imaging and immunological markers.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Neurodegeneration Underlying Distinct Disabilities in Multiple Sclerosis Using a Cell-Specific, Region-Specific, and Sex-Specific Approach
Neuroprotection in MS: A Cell-Specific and Region-Specific Transcriptomics Approach
Neuroprotection in MS: A Cell-Specific and Region-Specific Transcriptomics Approach
Neuroprotection in MS: A Cell-Specific and Region-Specific Transcriptomics Approach
海外基金